Kymera Therapeutics's market cap is currently $3.75B. The company's EPS TTM is $-0.95; its P/E ratio is ―; Kymera Therapeutics is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-0.76. See an overview of income statement, balance sheet, and cash flow financials.
